94 results
Page 3 of 5
8-K
EX-10.1
3uq5mqe
7 Aug 17
AntriaBio and ActiveSite Pharmaceuticals Announce License and Development Agreement for Plasma Kallikrein Inhibitors
12:00am
8-K
EX-10.1
risk88s 6hvhn1dgzs
6 Mar 17
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.7
qodw4hueoe
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.6
qc2gd
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
zch 9vx1fnl
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.3
oc67 bfc1y
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.4
r89q5plk4hp
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
hq7 9t0i8f6c6
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.5
92t9o647e07
29 Dec 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.2
uua3tc4bio9elps
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
0tr8fzdfzjdx
4 Nov 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
b6f gq6e740o
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.4
67c0s3km
29 Jun 16
AntriaBio Announces $12 Million Private Placement
12:00am
8-K
EX-10.1
u3s5f4j5cke8fk 7z7hv
2 Mar 16
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
b3pw1gp3
6 Apr 15
Entry into a Material Definitive Agreement
12:00am